Surgical management of recurrent cervical cancer

Yonsei Medical Journal

Volumn 43, Issue 6, 2002, Pages 754-762

  Selman, Alberto E ^a   Copeland, Larry J ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cervix neoplasms; Colonic diversion; Pelvic exenteration; Postoperative complications; Preoperative care; Prognosis; Quality of life; Recurrent cervical cancer; Survival rate; Treatment outcome; Urinary diversion; Vaginal reconstruction

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLON ANASTOMOSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTESTINE INJURY; LUNG EMBOLISM; PATIENT SELECTION; PELVIC DISEASE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; RADICAL HYSTERECTOMY; REVIEW; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; TREATMENT INDICATION; URINARY TRACT FISTULA; URINARY TRACT OBSTRUCTION; UTERINE CERVIX CANCER; VAGINA RECONSTRUCTION; WOUND DEHISCENCE; WOUND INFECTION;

EID: 0036957318     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.6.754     Document Type: Review

References (52)

1. Delgado G, Bundy BN, Fowler WC Jr, Stehman FB, Sevin B, Creasman WT, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989;35:314-20.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Monaghan JM. Surgical management of advanced and recurrent cervical carcinoma: the place of pelvic exenteration (Review). Clin Obstet Gynecol 1985;12:169-82
4. Cervical cancer (Review). NIH Consensus statement. 1996;14:1-38.
5. Gerdin E, Cnattingus S, Jognson P, Petterson B. Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy. Gynecol Oncol 1994;53:314-9.
6. Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A. Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 2002;81:351-5.
7. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone MM Jr, Edwards CL. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 1988;30:381-7.
8. Potter ME, Alvarez RD, Gay FL, Shingleton HM, Soong SJ, Hatch KD. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 1990;37:74-7.
9. Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Cancer 1981;48:899-903.
10. Bonomi P, Blessing J, Ball H. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Gynecol Oncol 1989;34:357-9.
11. Alberts DS, Mason-Liddil N. The role of cisplatin in the management of advanced squamous cell cancer of the cervix. Semin Oncol 1989;16:66-78.
12. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Cancer 1993 May;3:129-42.
13. Henriksen E. Lymphatic spread of cervix and corpus carcinoma. Am J Obstet Gynecol 1949;58:1924.
14. Jobsen JJ, Leer JW, Cleton FJ, Hermans J. Treatment of loco-regional recurrence of carcinoma of the cervix by radiotherapy after primary surgery. Gynecol Oncol 1989;33:368-71.
15. Sommers GM, Grigsby PW, Perez CA, Camel HM, Kao MS, Galakatos AE, et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 1989;35:150-5.
16. Perez CA, Breaux S, Madoc-Jones H, Bedwinek JM, Camel HM, Purdy JA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. Cancer 1983;51:1393-402.
17. Rubin SC, Hoskins WJ, Lewis JL Jr. Radical hysterectomy for recurrent cervical cancer following radiation therapy. Gynecol Oncol 1987;27:316-24.
18. Hockel M. Laterally extended endopelvic resection: surgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies. Am J Obstet Gynecol 1999;180:306-12.
19. Hockel M, Knapstein PG. The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients. Gynecol Oncol 1992;46:20-8.
20. Hockel M, Schlenger K, Hamm H, Knapstein PG, Hohenfellner R, Rosler HP. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996;77:1918-33.
21. Gallousis S. Isolated lung metastases from pelvic malignancies. Gynecol Oncol 1979;7:206-14.
22. Garton GR, Gunderson LL, Webb MJ, Wilson TO, Martenson JA Jr, Cha SS, et al. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience. Gynecol Oncol 1993;48:328-32.
23. Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol Oncol 1994;55:29-35.
24. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma: a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1948;1:177-83.
25. Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin North Am 1950;30:1511-21.
26. Goldberg JM, Piver MS, Hempling RE, Aiduk C, Blumenson L, Recio FO. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality. Ann Surg Oncol 1998;5:399-406.
27. Morris M, Bodurka-Bevers DC. Cervical Cancer. In: Copeland LJ, editor. Textbook of Gynecology. 2nd ed. Philadelphia: WB Saunders; 2000. p.1261-87.
28. Nag S, Martinez-Monge R, Mills J, Bauer C, Grecula J, Nieroda C, et al. Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol 1998;5:16-22.
29. Brunschwig A. What are the indications and results of pelvic exenteration? JAMA 1965;194:274-9.
30. Magrina JF. Types of pelvic exenterations: a reappraisal. Gynecol Oncol 1990;37:363-6.
31. Pearlman NW, Donohue RE, Stiegmann GV, Ahnen DJ, Sedlacek SM, Braun TJ. Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 1987;122:537-41.
32. Kim HK, Jessup JM, Beard CJ, Bornstein B, Cady B, Stone MD, et al. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiotherapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997;38:777-83.
33. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 1989;35:93-8.
34. Hancock KC, Copeland LJ, Gershenson DM, Saul PB, Wharton JT, Rutledge FN. Urinary conduits in gynecologic oncology. Obstet Gynecol 1986;67:680-4.
35. Curtin JP, Hoskins WJ. Pelvic exenteration for gynecologic cancers. Surg Oncol Clin North Am 1994;3: 267-76.
36. Bejany DE, Politano VA. Stapled and nonstapled tapered distal ileum for construction of a continent colonic urinary reservoir. J Urol 1988;140:491-4.
37. Ahlering TE, Weinberg AC, Razor B. Modified Indiana pouch. J Urol 1991;145:1156-8.
38. Hatch KD, Shingleton HM, Potter ME, Baker VV. Low rectal resection and anastomosis at the time of pelvic exenteration. Gynecol Oncol 1988;31:262-7.
39. Paty PB, Enker WE, Cohen AM, Minsky BD, Friedlander-Klar H. Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg 1994;167:90-4.
40. Grumann MM, Noack EM, Hoffmann IA, Schlag PM. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 2001;233:149-56.
41. Ratliff CR, Gershenson DM, Morris M, Burke TW, Levenback C, Schover LR, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer 1996;78:2229-35.
42. Kusiak JF, Rosenblum NG. Neovaginal reconstruction after exenteration using an omental flap and split-thickness skin graft. Plast Reconstr Surg 1996;97:775-81.
43. Copeland LJ. Reconstructive surgery in gynecologic oncology. In: Gershenson DM, DeCherney AH, Curry SL, Brubaker L, editors. Operative Gynecology. 2nd ed. Philadelphia: WB Saunders; 2001. p.780-802.
44. Copeland LJ, Hancock KC, Gershenson DM, Stringer CA, Atkinson EN, Edwards CL. Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration. Am J Obstet Gynecol 1989;160:1095-101.
45. Jain AK, DeFranzo AJ, Marks MW, Loggie BW, Lentz S. Reconstruction of pelvic exenteration wounds with transpelvic rectus abdominis flap: A case series. Ann Plast Surg 1997;38:115-22.
46. Rutledge FN, Smith JP, Wharton JT, O'Quinn AG. Pelvic exenteration: Analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-92.
47. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 Patients at 5 years. Obstet Gynecol 1989;74:934-43.
48. Morrow CP, Curtin JP, Lopez de la Osa E. Surgery for cervical neoplasia. In: Morrow CP, Curtin JP, Lopez de la Osa E, editors. Gynecologic Cancer Surgery. New York: Churchill Livingstone; 1996. p.451-568.
49. Averette HE, Lichtinger M, Sevin BU, Girtanner RE. Pelvic exenteration: A 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 1984;150: 179-84.
50. Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989; 73:1027-34.
51. Leake JF. Tumors of slow malignant potential (Review). Curr Opin Obstet Gynecol 1992;4:81-5.
52. Woodhouse CR, Plail RO, Schlesinger PE, Shepherd JE, Hendry WF, Breach NM. Exenteration as palliation for patients with advanced pelvic malignancy. Br J Urol 1995;76:315-20.